Encoded Therapeutics
  • Home
  • Our Science
    ⟵
      ⟵ Back
    • Overview
    • Genetic Medicines Product Engine
  • Pipeline & Programs
    ⟵
      ⟵ Back
    • Overview
    • Pipeline
    • Clinical Studies
    • ETX101 for Dravet Syndrome
    • Research Areas
    • Publications & Presentations
  • Patient
    Community
    ⟵
      ⟵ Back
    • Overview
    • Patient Community Stories
    • Dravet Syndrome
    • Pre-Approval Access Statement
  • Healthcare
    Professionals
  • About
  • News
    ⟵
      ⟵ Back
    • Overview
    • Press Releases
    • Media Kit
  • Careers
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Social Media Guidelines
Encoded Therapeutics
  • News
  • Careers
  • Contact
  • Home
  • Our Science
    • Overview
    • Genetic Medicines Product Engine
  • Pipeline &
    Programs
    • Overview
    • Pipeline
    • Clinical Studies
    • ETX101 for Dravet Syndrome
    • Research Areas
    • Publications & Presentations
  • Patient
    Community
    • Overview
    • Patient Community Stories
    • Dravet Syndrome
    • Pre-Approval Access Statement
  • Healthcare
    Professionals
  • About
    • Overview
    • Leadership
    • Board of Directors
    • Investors
  • ←   Back to Press Releases
April 23, 2024

ENVISION

  • Share
  • Post
  • Email
  • Copy Link

Cell-Selective Targeting and Regulation

The precision gene therapies being developed at Encoded are potentially capable of targeting specific cell types or levels of expression to address a range of disease mechanisms.

Learn more

Cell-Selective Targeting and Regulation

The precision gene therapies being developed at Encoded are potentially capable of targeting specific cell types or levels of expression to address a range of disease mechanisms.

Learn more

©Copyright 2026 Encoded Therapeutics, Inc.

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Social Media
    Guidelines

You are leaving encoded.com

This link leads outside the Encoded Therapeutics website and we are not responsible for that content.

Yes, I'd like to visit this link. No, I'd like to stay on encoded.com